Skip to content
  • About
  • Shop
  • News
  • Contact Us
Search
NECA Logo
  • NET Nurse
  • Donate
  • What are NETs?
    • What are Neuroendocrine Cancers?
    • What are Pheos & Paras?
    • NET Symptoms
    • NET Types
    • Causes
    • Treatments
    • Grades
    • Diagnosis
    • Prognosis
    Consider the Grey Area
  • Patients & Carers
    • Patient & Carer Support
    • Patient Resources
    • Optimal Care Pathway
    • NET Nurse
    • Patient Stories
    • Share your Story
    • Australian NET Specialists
    • Clinical Trials
    • Living with NETS
    • Specialist Support Services
    Consider the Grey Area
  • Healthcare Professionals
    • Optimal Care Pathway
    • Professional Learning
    • Patient Referral
    • Clinical Trials
    • NET Symptoms
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order Booklets & Resources
    Consider the Grey Area
  • Get Involved
    • Advocate for Us
    • Share your Story
    • Donate
    • Fundraise
    • Events
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Volunteer
    Senate MailChimp
  • March4NETs
NET Nurse
Donate

Home » Advocacy » ENETS wrap up from Kate Wakelin

ENETS wrap up from Kate Wakelin

  • March 27, 2018

Read Kate's reflections of ENETS below……

Early in March I was privileged to attend the European
Neuroendocrine Tumour Society annual conference in Barcelona, Spain.

What a wonderful opportunity to hear the latest updates and
emerging thinking about NETs, from every corner of the globe!

Some highlights included:

  • An increasing focus on nutrition in NETs, particularly
    around the issues of vitamin deficiencies associated with carcinoid
    syndrome and somatostatin analogue usage. It was great to see one of our
    wonderful Australian NET dietitians, Erin Kennedy provide both an
    oral and poster presentation.
  • Learning about the usage of intra-arterial PRRT,
    delivered directly to the liver via a catheter fed through an artery.
  • Very positive results from NETTER1 trial, demonstrating
    sustained effectiveness of PRRT.
  • Nursing specific content related to the management of
    carcinoid heart disease and nutrition.
  • I was also honoured to present alongside our wonderful
    Simone Leyden at the patient symposium, highlighting some of our call data
    with a focus on unmet needs.

We have returned to Australia feeling inspired and
energised, with much to do, knowing that we have many international friends
working towards the same goals!

   

Share this post

Recent posts

ACCN Innovations Showcase 2025

July 8, 2025

Radio National Interview: Changing Australia June 2025

June 30, 2025

Adelaide NET Patient Forum 2025

June 24, 2025

CNSA & ICCN 2025 Congress: Global Voices, Local Actions

June 24, 2025
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPreviousSurvivorship Conference Feb 2018
NextINCA Meetings Wrap from SimoneNext

Related Posts

ACCN Innovations Showcase 2025

The annual Australian Comprehensive Cancer Network (ACCN) Innovations Showcase was held at Peter MacCallum Cancer Centre in Melbourne this year. There were several hundred who

Radio National Interview: Changing Australia June 2025

Rare cancers can be extremely difficult to diagnose, and it can take years of misdiagnoses before a culprit is found and patients get adequate treatment.

Adelaide NET Patient Forum 2025

Pictured – DR Ria Joseph, Dr Chad Han, A/Prof Gabby Cehic, Meredith Cummins, Dr Rebekah Chew, Jessica Mercurio and Dr Rahul Solanki Thank you to

CNSA & ICCN 2025 Congress: Global Voices, Local Actions

NECA proudly attended the CNSA & ICCN 2025 Annual Congress, held at the Adelaide Convention Centre from 18–21 June 2025. This landmark event was a

View All

Subscribe to Newsletter

NECA Logo
registered charity badge

What are NETs

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Patients & Carers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

Healthcare Professionals

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
All charity donations to NeuroEndocrine Cancer Australia may be tax-deductible in Australia.

Registered Charity CFN 202607
© 2025 NeuroEndocrine Cancer Australia
  • Website by Five Creative
Twitter Facebook Youtube Instagram Linkedin